Background. The epithelial response to injury is stereotypical and reminiscent of epithelial-to-mesenchymal transitions (EMTs), such as those observed during embryogenesis and tumour metastasis. In the context of solid organ transplantation, EMT-like features are often acquired by epithelial cells and are predictive of graft fibrosis. Here, we studied the possible involvement of several major transcriptional regulators, including snail1, phospho-Smad 2/3 and zeb1, in EMT induction in human renal grafts. Methods. We used immunohistochemistry to detect the presence of these EMT transcriptional regulators along with that of two validated EMT markers (intra-cytoplasmic translocation of β-catenin, de novo expression of vimentin), in 103 renal graft biopsy samples taken for routine surveillance or for a clinical indication. Results. We observed the nuclear accumulation of snail1 and phospho-smad2/3 in tubular cells displaying EMT. The level of snail1 was significantly correlated with the scores of EMT markers (β-catenin: ρ = 0.94, P < 0.0001; vimentin: ρ = 0.93, P < 0.0001) and with deteriorated graft function and proteinuria at the time of biopsy. Furthermore, intense staining for both snail1 and vimentin in tubular cells (≥10% of tubules) was predictive of graft dysfunction 21 months post-biopsy, independently of the other known risk factor for long-term graft dysfunction. In contrast, in both normal and diseased graft, zeb1 expression was detected exclusively in the endothelial cells of glomeruli and peritubular capillaries.
A B S T R AC T
Background. The epithelial response to injury is stereotypical and reminiscent of epithelial-to-mesenchymal transitions (EMTs), such as those observed during embryogenesis and tumour metastasis. In the context of solid organ transplantation, EMT-like features are often acquired by epithelial cells and are predictive of graft fibrosis. Here, we studied the possible involvement of several major transcriptional regulators, including snail1, phospho-Smad 2/3 and zeb1, in EMT induction in human renal grafts. Methods. We used immunohistochemistry to detect the presence of these EMT transcriptional regulators along with that of two validated EMT markers (intra-cytoplasmic translocation of β-catenin, de novo expression of vimentin), in 103 renal graft biopsy samples taken for routine surveillance or for a clinical indication. Results. We observed the nuclear accumulation of snail1 and phospho-smad2/3 in tubular cells displaying EMT. The level of snail1 was significantly correlated with the scores of EMT markers (β-catenin: ρ = 0.94, P < 0.0001; vimentin: ρ = 0.93, P < 0.0001) and with deteriorated graft function and proteinuria at the time of biopsy. Furthermore, intense staining for both snail1 and vimentin in tubular cells (≥10% of tubules) was predictive of graft dysfunction 21 months post-biopsy, independently of the other known risk factor for long-term graft dysfunction. In contrast, in both normal and diseased graft, zeb1 expression was detected exclusively in the endothelial cells of glomeruli and peritubular capillaries.
Conclusion. This study suggests that snail1 is closely related to the fibrogenic, EMT-like response of the tubular epithelium in human renal grafts and predictive of graft function loss.
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I N T RO D U C T I O N
Epithelia respond to injury in adult organs in a stereotypical manner. Under assault, epithelial cells will cease performing the physiological functions for which they are programmed (as in a diapause [1] ) and acquire a number of mesenchymal features [2] . The presence of mesenchymal molecules that are usually expressed by fibroblasts are accepted criteria for 'epithelial-to-mesenchymal transition' (EMT) [3] . However, we are still ignorant of the real consequences of EMT in adult organs, because the results of lineage-tracing studies are contradictory [4] [5] [6] [7] . Since the EMT acronym is often taken to refer to cellular transit (rather than a simple transition from one phenotype to another), the latest report from the BANFF working group has asked for a new term to be coined to designate the epithelial response to injury in the context of solid organ transplantation [8] . Our previous analysis of data from several different renal transplantation centres did show that detecting EMT-like features was useful for renal graft surveillance: the expression in tubular epithelial cells of human renal grafts of these 'EMT-like' features was closely associated with graft injury indicators [low estimated glomerular filtration rate (eGFR), proteinuria] at the time of the biopsy [9] , but the latter were not reflected by the current morphological analysis scores of the Banff classification [10] . The expression of EMTlike markers by tubular cells in renal grafts was both frequent and associated with known graft pro-fibrotic events, such as graft ischemia, rejection or cyclosporin administration [11, 12] . It was also of poor prognostic value with regard to the progression of interstitial fibrosis [13] or long-term graft function deterioration [9, [12] [13] [14] [15] when these markers were measured at a time point after the physiological graft repair period that follows surgery-related ischemia-reperfusion injury and not before 3 months [16] . Similar findings have been observed in liver and lung transplants [8] . EMT is thus a source of potential biomarkers, and as such, it is currently being tested in a clinical trial for evaluating anti-fibrotic strategies at the bedside (NCT#01079143).
In the present study, we investigated the hypothesis that snail1, phospho-smad2/3, and zeb1, three essential transcriptional regulators for EMT initiation in the setting of embryogenesis and cancer metastasis, could be involved in the induction of EMT in injured human renal grafts. Snail1 binds to and acts as a repressor of the promoter of E-cadherin, a key adhesion molecule for epithelial cells [17] . Loss of E-cadherin compromises cell polarity and allows an intermediate molecule, β-catenin, to leave the site of the adherens junction and act as a co-transcription factor in enhancing the transcription of mesenchymal genes. The importance of snail1 in initiating the EMT program in adult organs is suggested by two experimental studies: (a) renal tubules from transgenic mice overexpressing snail1 in the kidney rapidly developed phenotypic changes reminiscent of EMT (loss of E-cadherin, fibroblastlike morphological changes, and expression of mesenchymal proteins, such as vimentin), along with interstitial fibrosis, and rapidly progressive renal failure [18] ; (b) in mice used as a model of fibrotic liver disease (injected with carbon tetrachloride), the hepatocyte-specific knock-out of snail1 preserved the epithelial phenotype, prevented the mesenchymal phenotype switch, and reduced collagen I accumulation [19] . Snail1 mRNA has been shown to be elevated in fibrotic human kidneys [18] , and the snail1 protein, which is barely detectable in normal kidneys, is present in high levels in myeloma cast nephropathy (a disease characterized by a rapid fibrogenesis) [20] and in IgA, as well as in diabetic nephropathy [21] . The expression of snail1 in human kidney transplants has not been specifically studied as a marker of EMT for predicting graft fibrosis. Zeb1 is another transcriptional repressor and is also capable of blocking the expression of E-cadherin in epithelial cell lines. Zeb1 has been shown to be induced by snail1, and its stability is also dependent on snail1 via the endogenous micro-RNA-200s (miR-200s) loop or an unidentified ubiquitin ligase [22] . Zeb1 regulates EMT via a double negative feedback loop with miR-200s, the expression of which was down-regulated by snail1, Zeb1, and by transforming growth factor β [15] , an initiator of EMT [23] , mainly via the phospho-smad pathway [15] . To the best of our knowledge, Zeb1 has never been investigated in human kidneys.
Here, in order to investigate the possible involvement of snail1, phospho-smad 2/3 and Zeb1 in EMT induction in injured human renal grafts, we used immunohistochemistry to detect the expression of these three members of the pro-EMT loop in the tubular epithelial cells of human renal grafts.
M AT E R I A L S A N D M E T H O D S

Biopsy samples
The leftover material from 103 renal graft biopsies taken from 91 adult kidney recipients between 2006 and 2010 was available for the study of the markers. In accordance with the French law for non-interventional studies using leftover human samples (Public Health Code, article L1121-1, revised in May 2009), all patients were invited to participate in the study after giving oral consent. Most of the patients (88.8%) had received a graft from a deceased donor, and the others (11.2%) from living donors. The mean recipient age was 49 years at the time of biopsy, and 68.3% of recipients were male. The mean donor age was 53.7 years. The mean cold ischemia time was 1111 min (18.5 h). The immunosuppressive regimen consisted essentially of conventional triple-therapy including a calcineurin inhibitor (CNI), corticosteroids, and mycophenolate mofetil. Only four patients were on a CNI-free regimen and treated with rapamycin, an mammalian target of rapamycin inhibitor.
Forty-four biopsies (43%) were performed for graft surveillance, 84% of them were taken at 3 months post-transplant, and 59 (57%) were carried out for a clinical indication (delayed graft function after transplant surgery, or following acute deterioration of graft function at later time points).
Histopathological analysis was scored according to the updated Banff working classification for renal graft pathology [10] . Thirty-two of the biopsies indicated acute rejection, including eight that were subclinical and diagnosed by the surveillance biopsy. Twenty-one displayed acute tubular necrosis and 16 CsA toxicity-related lesions. The mean Banff acute scores were 0.75, 0.46, 0.34, and 0.39 for i, t, g, and ptc, respectively, and the chronic scores were 0.14, 0.78, 0.67, and 0.87 for cg, ci, ct, and cv, respectively.
Three normal kidney samples obtained from the healthy parts of kidneys that had been removed because of a malignant tumour, plus three implantation biopsies, were used as controls.
Immunohistochemistry of transcription factors (snail1, Zeb1, and phospho-smad2/3) and of EMT markers (β-catenin and vimentin) Immunohistochemistry was performed on paraffin-embedded tissues as described previously [11, 13] . Target retrieval was carried out by heating the tissue in a citrate buffer (Dako cytomation) at pH 6 for snail1, phospho-smad2/3, β-catenin, and vimentin, or at pH 9 for Zeb1. Endogenous peroxidase was inactivated by incubating the specimen for 10 min at room temperature in 0.03% H 2 O 2 . The sections were incubated overnight at 4°C with phosphate-buffered saline containing 1/3000 antisnail1 (rabbit polyclonal antibody; abcam), 1/3000 antiphospho-smad2/3 (rabbit polyclonal antibody; Santa Cruz Biotechnology), 1/2500 anti-Zeb1 (rabbit polyclonal antibody, kindly provided by Dr Darling), 0.1 µg/mL anti-β-catenin (rabbit polyclonal antibody; Santa Cruz Biotechnology), and 1:4000 anti-vimentin (mAb V9; Zymed). The immunoreactive proteins were visualized using the Envision + HRP system (AEC; DakoCytomation). Finally, the tissue sections were counterstained with hematoxylin and mounted using aqueous mounting medium (Dako). The primary antibodies were replaced by equal concentrations of rabbit or mouse IgG (Dako) as negative controls.
Semi-quantitative analysis of immunohistochemical staining
The nuclear accumulation of the transcriptional factor (snail1) and the tubular expression of EMT markers (β-catenin and vimentin) were measured as described previously [11, 20] , by the semi-quantitative determination of the proportion of tubules displaying positive staining (0, none; 1, < 10%; 2, 10-24%; 3, 2-50%; 4, >50%). EMT+ or snail1+ graft designates a graft in which at least 10% of tubules displayed both the de novo expression of vimentin and the intracellular translocation of β-catenin or nuclear staining for snail1. All stained tissues were scored three times in a blind fashion by YCXD, who had no knowledge of the clinical, biological, or morphological data, including the result of immunostaining scores. We did not quantify the tubular nuclear accumulation of phospho-smad2/3, because its basal expression in the normal kidneys was so strong in the distal tubules and in collecting ducts, so the quantification would have been doubtful in diseased conditions. Similarly, Zeb1 was not quantified, since it was not detectable in the tubular epithelial cells of normal or diseased renal grafts.
Statistical analysis
The association between the patient's clinical and morphological data (eGFR, proteinuria, and Banff scores) at the time of biopsy and the markers studied here was assessed by Spearman's rank correlation. Results were reported as Spearman's coefficient, ρ, with the associated P-value. The clinical data were also compared according to the snail1 and/or EMT status ( positive versus negative) by the unpaired t-test and Wilcoxon's rank-sum test. The results were reported as the mean ± SE, with the P-value generated from a t-test for continuous values or from the Wilcoxon's rank-sum test for ordinal values or to compare groups containing less than 30 biopsies. Logistic regression was used to estimate the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of potential risk factors for low graft function at 21 months after biopsy. The cutoff point for eGFR (36 mL/min) was determined as the median eGFR at this time. For this analysis, only one biopsy for each patient was included in the model: when a patient had more than one biopsy, the graft surveillance biopsy or the biopsy carried out more than 3 months post-transplant was used. This decision was made before we performed the statistical analysis. Statistical analysis was carried out using STATA 8 (Stata Corp. College Station, TX, USA). The test was defined as being significant if P < 0.05.
R E S U LT S
Nuclear accumulation of snail1 and phospho-smad2/3, but not of Zeb1, in tubular epithelial cells of renal graft biopsies In the normal kidneys and in renal implant biopsies, nuclear snail1 staining was either absent or very faint in the proximal tubules and was weakly detectable in the distal tubules and collecting ducts (Figure 1a) . In the diseased graft kidneys, we found intense nuclear snail1 staining in many tubules, including the proximal tubules (Figure 1b and e) . In normal kidneys, strong phospho-smad2/3 staining was found in the distal tubules and the collecting ducts, but relatively weaker staining in the proximal tubules (Figure 1c ). In the diseased renal grafts, strong nuclear phosphor-smad2/3 staining was seen in a large number of tubules (Figure 1d) .
Zeb1 was undetectable in tubular epithelial cells, in either normal (Figure 1f ) or diseased graft kidneys (Figure 1g ), even when EMT markers were present. This was not due to a failure to detect Zeb1 with the antibody that we used since (i) clear nuclear staining of Zeb1 was found in the endothelial cells of glomeruli and peritubular capillaries from both the native (Figure 1f ) and the transplanted (Figure 1g ) kidneys, and (ii) as a positive control, we used a (uterine) tumour sample, in which Zeb1 was detected in the nuclei from epithelial and stromal cells (Figure 1h) . The presence or the absence of EMT in graft kidneys did not affect the intensity of endothelial Zeb1 expression that was observed.
Expression of EMT markers (β-catenin, vimentin) and their co-localization with nuclear snail1 or phosphosmad2/3 expression in tubular epithelial cells As reported previously [11, 13] , in the normal kidneys, we observed β-catenin expression at the basal pole of proximal tubular epithelial cells, at the basolateral surface of distal tubules, and of collecting ducts (Figure 2a) . No vimentin expression could be detected in the epithelial cells of the normal kidneys or in implant biopsies (Figure 2b ). In contrast, increased expression and intracellular translocation of β-catenin (Figure 2c ) as well as de novo vimentin expression (Figure 2d ) were observed and were co-localized in serial sections (Figure 2c and d) in some of the graft kidneys.
Nuclear accumulation of snail1 (Figure 2e ) was mainly found in tubules displaying the EMT-like phenotypic changes described above (Figure 2f ). Similar results were obtained for phospho-smad2/3, the expression of which (Figure 2g ) was greater in vimentin+ tubules (Figure 2h ). Confocal microscopy was used to confirm that the de novo expression of vimentin was present in the tubules displaying nuclear staining of snail1 (Figure 2i ) and phospho-smad2/3 (Figure 2j ).
Spearman's rank correlation analysis showed that the nuclear staining score for snail1 was strongly correlated with that for vimentin (ρ = 0.93, P < 0.0001) and with that for β-catenin (ρ = 0.94, P < 0.0001). This was true whether the biopsies had been taken in response to a clinical indication (ρ = 0.9, P < 0.0001 for vimentin; ρ = 0.94, P < 0.0001 for β-catenin) or for graft F I G U R E 1 : Snail1 and phospho-smad2/3, but not of Zeb1, accumulate in the nuclei of tubular epithelial cells from human renal grafts. In the normal kidneys, no nuclear snail1 staining was seen in the proximal tubular epithelial cells, and only moderate staining in those of the distal tubules and collecting ducts (a). In contrast, intense nuclear snail1 staining was detectable in numerous tubules in pathological grafts (arrows) (b and e). Strong nuclear phospho-smad2/3 staining was observed in distal tubules and collecting ducts and less intense nuclear staining in the proximal tubules from normal kidney (c). Nuclear phospho-smad2/3 expression was observed in a more diffused pattern in tubules from pathological grafts and in particular it was strong in proximal tubules (arrows) (d). 
O R I G I N A L A R T I C L E
S n a i l 1 i n k i d n e y t r a n s p l a n t s surveillance (ρ = 0.95, P < 0.0001 for vimentin; ρ = 0.94, P < 0.0001 for β-catenin).
Association between the tubular nuclear expression of snail1 and of the mesenchymal cell marker vimentin with graft histological lesions (Banff scores), graft dysfunction, and proteinuria Spearman's rank correlation showed that both vimentin and snail1 were significantly correlated with the Banff acute (i and ptc) and chronic (ci, ct) scores (Table 1) and with a low eGFR [14] (ρ = −0.6, P < 0.0001 for snail1; ρ = −0.645, P < 0.0001 for vimentin, Table 1 ) and proteinuria (ρ = 0.38, P = 0.0005 for snail1; ρ = 0.444, P < 0.0001 for vimentin) at the time of the biopsy. The significant correlation between snail1 or vimentin and eGFR at this time point was observed in both surveillance biopsies (ρ = −0.4, P = 0.008 for snail1; ρ = −0.47, P = 0.0015 for vimentin) and biopsies intended for a clinical indication (ρ = −0.56, P < 0.0001 for snail1; ρ = −0.58, P < 0.0001 for vimentin). In fact, the correlation was also observed in biopsies both very early during the time course, pre-3 months post-transplant (ρ = −0.6, P = 0.0022 for snail1; ρ = −0.58, P = 0.0027 for vimentin), and after more than 3 months (ρ = −0.6, P < 0.0001 for snail1; ρ = −0.63, P < 0.0001 for vimentin). However, as shown in Table 2 , the Banff scores themselves were not significantly correlated with renal graft injury indicators, such as eGFR at the time of the biopsy.
Nevertheless, unlike the acute scores, Snail or vimentin expression in tubular epithelial cells and the Banff chronic ci, ct, F I G U R E 2 : Co-localization of snail1 and phospho-smad2/3 as well as β-catenin with vimentin. A very thin line of physiological β-catenin staining was seen at the basal pole of tubules in the normal kidney (a), but this staining was greater and displaced (intra-cytoplasmic translocation) in tubules (arrows) from diseased grafts (c). In these tubules, serial sections showed the de novo expression of vimentin (arrows), a mesenchymal cell marker (d), which was not seen in the tubules in the normal kidney (b). Serial sections also showed that the nuclear accumulation of snail1 (arrows) (e) was closely associated with the acquisition of vimentin (arrows) (f ). Similarly, phospho-smad2/3 (arrows) (g) accumulated in tubules that were strongly positive for vimentin (arrows) (h) in serial sections. Confocal microscopy was used to show that the nuclear accumulation of snail1 (arrows) (red, i) and of phospho-smad2/3 (red, j) co-localized in EMT+ tubules expressing vimentin (green, i and j).
cg, and cv scores were good predictors of the deterioration of eGFR at 9 and 21 months post-biopsy (Table 2) . Figure 3 shows the graft function, at the time of the biopsy, 9 and 21 months later, according to the fibrotic status (a graft was classified as being fibrotic when ci and ct scores ≥2) and in terms of the level of snail1 expression in the nuclei of tubular cells (a graft was classified as snail1+ when ≥ 10% of tubules displayed nuclear snail1 staining). As expected, patients with a fibrotic graft and who also expressed snail1 progressively lost their graft function over time (with a mean loss of 10 mL/min over 21 months). In patients with a fibrosis-free graft, nuclear staining for snail1 was associated with poorer graft function at the time of the biopsy (eGFR: m = 26.7 ± 2.7 versus 49.4 ± 2.7 mL/min, P < 0.0001), and despite some recovery after biopsy continued to display persistent significantly lower graft function at 9 (m = 35.7 ± 3.5 versus 50 ± 2.9, P = 0.0031) and 21 months (m = 28 ± 3.8 versus 47.5 ± 3.3, P = 0.0009) after biopsy than those who were free of both significant fibrosis and snail1 expression. In this latter group, graft function remained remarkably stable over time (Figure 3) . This was not due to any difference in graft fibrosis (m = 0.5 versus 0.6, P = 0.4; m = 0.35 versus 0.5, P = 0.17 for the comparison of the ci or ct scores in these two groups, respectively).
Logistic regression analysis showed that the tubular expression of snail1 or of vimentin was an independent risk factor for predicting a low eGFR (<36 mL/min) at 21 months postbiopsy, with an OR of 11.8 (95% CI = [2.6-55], P = 0.002) for snail1 and an OR of 4.62 (95% CI = [1. , P = 0.023) for vimentin after adjustment for some known risk factors or events for the long-term loss of graft function, such as donor age, cold ischemia time, graft inflammation i, ptc, or graft fibrosis, ci, and cv scores (Table 3) .
D I S C U S S I O N
Our study yielded three major findings. First, the expression of snail1 in the nuclei of tubular epithelial cells co-localizes with two major markers of EMT-like features known to predict graft fibrosis and its progression in human kidney recipients, namely the de novo expression of vimentin and the translocation of β-catenin into the cytoplasm. Second, like the EMT marker vimentin, Snail1, but not the conventional morphological lesions scored by the Banff classification, was a sensitive marker of graft injury and fibrosis. Third, quantifying snail1 and vimentin staining in tubules by immunohistochemistry of a biopsy sample provides prognostic information about longterm renal graft function loss, and this prognostic value was independent of existing graft fibrosis. During kidney development, the mesenchyme adjacent to the nephrogenic mesenchyme expresses snail1 genes, which are critical in tissue formation [18] . Once the differentiation of the kidney is complete, these genes are repressed, but they can be induced again, for example, in the rat model of ureteral obstruction [24] or in rapidly fibrotic myeloma cast nephropathy in humans [20] . Recently, the increased expression of snail1 has also been reported in tubular epithelial cells from human kidneys displaying diabetic nephropathy lesions or IgA nephropathy [21] . Snail1 probably plays a major role in renal fibrogenesis, since the reactivation of its expression is sufficient to induce renal fibrosis in adult mice, even in the absence of any epithelial injury [18] . The general view is that it promotes fibrosis by activating an EMT program, as in tumours, where the nuclear accumulation of snail1 is associated with E-cadherin repression, tumour recurrence, and metastasis.
So far, very little was known about snail1 expression in human transplanted kidneys, which are very prone to fibrosis. In this study, we observed that snail1 was expressed in tubules showing phenotypic alterations known to predict graft fibrosis [13] , which suggests-although it does not prove-that snail1 is involved in activating an EMT program in the kidney. More importantly, though, we found that snail1 expression in grafts that were free of significant fibrosis reflected graft dysfunction (as attested by lower eGFR and higher proteinuria at the time of the biopsy), and the graft did not go on to recover completely from this dysfunction (even if the snail1+ grafts did not display fibrotic lesions, they did not perform as well as snail1-grafts in the long term). One possible explanation is that the reactivation of snail1 is followed by an excessive repair response and/or by the initiation of a self-perpetuating fibrotic process. Fibrosis of the graft leads to loss of function. We do not have a second biopsy to prove it in this cohort, but in our previous studies we investigated this issue and found that 
Evolution of graft function, estimated using the MDRD equation (eGFR), based on the IF/TA score (a graft with ci/ct scores of ≥2 was classified as an IF/TA+ graft) and the snail1 status (a graft with at least 10% of tubules staining positive for snail1 in the nuclei was defined as a snail+ graft). Positive snail1 staining was closely associated with significantly poorer graft function even in non-significantly fibrotic grafts compared with those without snail1 expression both at the time of biopsy (P < 0.0001) and at later time points (at 9 months post-biopsy, P = 0.0031; at 21 months, P = 0.0009).
significant renal graft fibrosis progression was observed in grafts expressing an EMT marker at an early stage (at the 3-month surveillance biopsy) [13] . A possible alternative explanation is that this reactivation reflects an uncontrolled epithelial injury, which leads to the subsequent loss of graft function. This is of interest, because if this is true, the detection of snail1 as well as of the EMT marker, vimentin, could provide a useful early marker for assessing transplant injuries that may not always be detectible by conventional morphologic analysis. This early and sensitive marker could help us to improve our graft surveillance. Zeb factors are important transcription repressors that induce EMT by suppressing the expression of various epithelial genes in different kinds of human cancers. Zeb1 also suppresses the expression of tubular basement membrane components, which could facilitate the migration of epithelial cells. To the best of our knowledge, Zeb1 expression has never been reported in the kidneys. Here, we used a validated antibody against Zeb1 that in our hands produced positive nuclear staining in epithelial and stromal cells from a malignant tumour, as previously reported by others [25] . In the native as well as the transplant kidneys, the nuclear expression of Zeb1 was found exclusively in the endothelial cells from glomeruli and peritubular capillaries, whether or not histological lesions were detected. Zeb1 expression was not found in tubules showing phenotypic changes suggestive of EMT. This finding is in keeping with the absence of Zeb1 expression that has been reported even in a CCl4-induced model of liver fibrosis (an acute model of liver fibrosis during which snail1 is induced) [19] . Taken together, these data suggest that in contrast to tumour-associated EMT, Zeb1 does not play a critical role in fibrosis-associated tubular EMT.
In conclusion, the reactivation of snail1 expression in human renal grafts could be essential to switch on a fibrogenic, EMT programme in tubular epithelial cells. In grafts that are not yet fibrotic, the presence of snail1 reflects an ongoing injury and may predict the loss of renal function in the long term.
A U T H O R S ' CO N T R I B U T I O N S
Y.-C.D.-X. (yi-chun.dubois-xu@tnn.ap-hop-paris.fr) participated in designing and carrying out the study, data analysis, and writing the paper; P.G. (galichon@orange.fr) was involved in carrying out the study; I.B. (isabelle.brocheriou@tnn.aphp. fr) was involved in carrying out the study; E.B. (edithbaugey@ hotmail.fr) was involved in carrying out the study; N.O. (nacera.ouali@tnn.aphp.fr) was involved in carrying the data analysis; C.J. (chantal.jouanneau@tnn.aphp.fr) was involved in carrying out the study; R.M. (romain.morichon@upmc.fr) was involved in carrying out the study; E.R. (eric.rondeau@tnn. aphp.fr) was involved in writing the paper. A.H. (alexandre. hertig@tnn.ap-hop-paris.fr) was involved in carrying out the data analysis and writing the paper.
AC K N OW L E D G E M E N T S
We would like to thank Douglas S. Darling (Department of Oral Health and Rehabilitation, and Center for Genetics and Molecular Medicine, Louisville, Kentucky) for providing us with the anti-zeb1 antibody. We are grateful to Monika Ghosh for revising the English text.
CO N F L I C T O F I N T E R E S T S TAT E M E N T
None declared.
R E F E R E N C E S
